Seeking Alpha

TetraLogic prices IPO

  • TetraLogic Pharmaceuticals (TLOG) prices its 7.15M share IPO at $7 per share. The underwriter greenshoe option is for 1.0725M shares.
  • From IPOdesktop's IPO preview: A clinical-stage biopharmaceutical company, TetraLogic is focused on discovering and developing novel small molecule therapeutics that mimic Second Mitochondrial Activator of Caspases, or SMAC-mimetics, and are designed to cause or enable abnormal cells that are resistant to the body's immune system to self-destruct.
  • The company currently has no revenue and no collaboration partners.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|